SCHEMBL787443

SCHEMBL787443

NC[CH]c1ccccc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23501487 0.85 TAAR1 (0.50)
SCHEMBL577389 0.78 CYP2A6 (0.43)
SCHEMBL2142092 0.78 ALDH1A1 (0.56)
SCHEMBL3012 0.73
SCHEMBL5329192 0.72 MAOA (0.46)
Benzaldehyde SCHEMBL6690533 0.72 ALDH1A1 (0.74)
SCHEMBL4758209 0.72 ABAT (0.52)
Benzaldehyde SCHEMBL28468098 0.72 ALDH1A1 (0.74)
SCHEMBL460826 0.72 IDO1 (0.58)
SCHEMBL5999151 0.72 ALDH1A1 (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 429 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024130101-A1 HYDROGEL COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME WAKE FOREST UNIVERSITY HEALTH SCIENCES (US) 2024-06-20 WO claimed
CN-105916499-B 12-epi-pleuromutilins 纳布里瓦治疗股份公司 2020-02-18 CN claimed
CN-105916499-A 12-epi-pleuromutilins 纳布里瓦治疗股份公司 2016-08-31 CN claimed
CN-105722556-A Improved antiperspirant compositions 里曼贸易有限责任公司 2016-06-29 CN claimed
US-20150148394-A1 ESTER PRO-DRUGS OF [3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL] METHANOL FOR TREATING SKIN DISEASES AND CONDITIONS ALLERGAN INC (US) 2015-05-28 US claimed
CN-101910168-B Tropane compounds EXELIXIS INC 2014-07-30 CN claimed
EP-1658291-B1 SUBSTITUTED 8-HETEROARYL XANTHINES DOGWOOD PHARMACEUTICALS INC (US) 2013-10-02 EP claimed
EP-2629777-A2 BICYCLIC DIAMINES AS JANUS KINASE INHIBITORS Merck Sharp & Dohme Corp. (US) 2013-08-28 EP claimed
CN-102892492-A Delivery particle PROCTER & GAMBLE 2013-01-23 CN claimed
WO-2012054364-A2 BICYCLIC DIAMINES AS JANUS KINASE INHIBITORS MERCK SHARP & DOHME CORP. (US) 2012-04-26 WO claimed
WO-1994022840-A1 SUBSTITUTED CAPROLACTAMS AND DERIVATIVES THEREOF USEFUL FOR TREATMENT OF HIV DISEASE THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1994-10-13 WO claimed
WO-1994019329-A1 SUBSTITUTED CYCLIC CARBONYLS AND DERIVATIVES THEREOF USEFUL AS RETROVIRAL PROTEASE INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1994-09-01 WO claimed
CN-1071577-A Handle the toxicity of chemotherapy reagent and Anti-virus agent with acylated pyrimidine nucleosides PRO NEURON INC (US) 1993-05-05 CN claimed
EP-0190946-B1 NOVEL CYCLIC HEXAPEPTIDE LHRH ANTAGONISTS MERCK & CO. INC. (US) 1993-01-20 EP claimed
EP-0206118-B1 CYCLIC HEXAPEPTIDE SOMATOSTATIN ANALOGS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM MERCK & CO. INC. (US) 1992-07-22 EP claimed
US-4703034-A HYPOGLYCEMIC AGENT MERCK & CO., INC. (US) 1987-10-27 US claimed
EP-0206118-A2 Cyclic hexapeptide somatostatin analogs, process for their preparation and pharmaceutical compositions containing them MERCK & CO. INC. (US) 1986-12-30 EP claimed
US-4612366-A Cyclic hexapeptide somatostatin analogs MERCK & CO., INC. (US) 1986-09-16 US claimed
US-4611054-A GLUCAGON, GROWTH HORMONE AND INSULIN RELEASE INHIBITORS MERCK & CO., INC. (US) 1986-09-09 US claimed
EP-0190946-A2 Novel cyclic hexapeptide LHRH antagonists MERCK & CO. INC. (US) 1986-08-13 EP claimed